KETOPROFENE CRISTERS LP 200 mg, extended-release coated tablet 14 tablets
Active ingredients: KÉTOPROFÈNE
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release coated tablet14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KETOPROFENE CRISTERS LP 200 mg, comprimé enrobé à libération prolongée
- Pharmaceutical form
- comprimé enrobé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 14 comprimé(s)
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Jul 2010
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62013467CIP73783451CIP133400937834513Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KÉTOPROFÈNEcomprimé | 200 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.